TrialNature medicine2025

Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial.

Yelena Y Janjigian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.